Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3479655

CC(C)Oc1cccc(CN2CCC3(CC2)CN(C)C(=O)N3c2cc(F)ccc2-c2ccc(S(=O)(=O)N(C)C)cc2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.36
FAAH O00519 1/20 0.35
BRS3 P32247 1/20 0.34
GPR6 P46095 1/20 0.34
MMP1 P03956 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
ADAM17 P78536 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
NR1H2 P55055 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
SSTR5 P35346 1/20 0.32
KCNH2 Q12809 1/20 0.32
PTGDR Q13258 1/20 0.32
CCR3 P51677 1/20 0.32
ROCK2 O75116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479457 0.95 BACE1 (0.39) BACE1FAAHMMP1MMP9MMP13
Trifluoroacetic Acid SCHEMBL3479483 0.93 BACE1 (0.35) BACE1FAAHGPR6MMP1MMP9
SCHEMBL3479696 0.88 BACE1 (0.37) BACE1MMP1MMP9MMP13ADAM17
Trifluoroacetic Acid SCHEMBL3479427 0.87 NR1H2 (0.35) BACE1FAAHBRS3GPR6MMP1
SCHEMBL3479526 0.86 BACE1 (0.39) BACE1FAAHBRS3MMP1MMP9
Trifluoroacetic Acid SCHEMBL3479514 0.83 BACE1 (0.38) BACE1FAAHBRS3MMP1MMP9
SCHEMBL3479470 0.83 JAK2 (0.35) BACE1MMP1MMP9MMP13ADAM17
SCHEMBL3479554 0.82 JAK2 (0.37) BACE1MMP1MMP9MMP13ADAM17
SCHEMBL3479638 0.81 JAK2 (0.35) BACE1MMP1MMP9MMP13ADAM17
SCHEMBL13031015 0.81 JAK2 (0.36) BACE1MMP1MMP9MMP13ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298342-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease MERCK & CO., INC. (US) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298342-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease BACE1, APP, PSEN1 BACE1 1/4885FAAH 1494/4885BRS3 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.